 Kezar Life Sciences, Inc. Nasdaq: KZR, a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer today announced that it will release its second quarter financial results on Thursday, August 5, 2020 after the market closes. Kezars executive team will host a conference call to discuss the companys second quarter 2020 financial results and provide a general business update. 